Brief: Entrada Therapeutics Collaborates With Myotonic Dystrophy Clinical Research Network
04/08/2022 12:49
Aug 4 (Reuters) - Entrada Therapeutics Inc TRDA.O :
* ENTRADA THERAPEUTICS ANNOUNCES COLLABORATION WITH THE
MYOTONIC
DYSTROPHY CLINICAL RESEARCH NETWORK TO STUDY THE NATURAL HISTORY
OF MYOTONIC DYSTROPHY TYPE 1
Source text for Eikon: ID:nGNXb62MYJ
Further company coverage: TRDA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entrada Therapeutics
See all newsBrief: Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Entrada Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Entrada Therapeutics Q2 Collaboration Revenue USD 898 Thousand
Entrada Therapeutics Q2 net loss narrows on lower costs
Entrada Therapeutics Inc expected to post a loss of $1.05 a share - Earnings Preview